Scinai Immunotherapeutics (SCNI) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free SCNI Stock Alerts $3.75 +0.15 (+4.17%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 24, 2024 | prnewswire.comScinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining ComplianceMay 15, 2024 | prnewswire.comScinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business UpdateMay 6, 2024 | finanznachrichten.deScinai Immunotherapeutics Ltd.: Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and AppealMay 6, 2024 | prnewswire.comScinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and AppealApril 17, 2024 | morningstar.comScinai Immunotherapeutics Ltd ADR SCNIApril 10, 2024 | prnewswire.comScinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMGApril 9, 2024 | theglobeandmail.comScinai Immunotherapeutics (NASDAQ: SCNI), Scinai Bioservices Enter MSA with Ayana PharmaApril 8, 2024 | prnewswire.comScinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing ServicesMarch 12, 2024 | finance.yahoo.comScinai leadership to attend BIO-Europe Spring 2024February 29, 2024 | prnewswire.comScinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024February 13, 2024 | finance.yahoo.comScinai Welcomes Liat Halpert as Head of Business Development and SalesFebruary 3, 2024 | morningstar.comScinai Immunotherapeutics Ltd ADRJanuary 25, 2024 | finance.yahoo.comScinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet PrizeJanuary 4, 2024 | finance.yahoo.comScinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross ProceedsJanuary 4, 2024 | finanznachrichten.deScinai Immunotherapeutics Ltd.: Scinai Immunotherapeutics CEO Issues Letter to ShareholdersJanuary 4, 2024 | finance.yahoo.comScinai Immunotherapeutics CEO Issues Letter to ShareholdersDecember 29, 2023 | msn.comScinai Immunotherapeutics to raise $1.7M through exercise of outstanding warrantsDecember 29, 2023 | finance.yahoo.comScinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross ProceedsDecember 27, 2023 | finance.yahoo.comScinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar on January 9December 23, 2023 | wsj.comScinai Immunotherapeutics Ltd. ADRDecember 21, 2023 | investing.comScinai Immunotherapeutics Ltd ADR (SCNI)December 12, 2023 | finance.yahoo.comScinai Announces Promising Results in a Psoriatic Human Skin ModelDecember 11, 2023 | finance.yahoo.comStudy published in Antiviral Research supports promise of Scinai Immunotherapeutics' coronavirus NanoAb as aerosolized prophylactic and therapeutic drugNovember 28, 2023 | finance.yahoo.comScinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity RuleNovember 20, 2023 | msn.comScinai Immunotherapeutics regains compliance with stockholders' equity ruleNovember 6, 2023 | finance.yahoo.comScinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business UnitNovember 3, 2023 | finance.yahoo.comScinai Immunotherapeutics to Attend BIO-Europe Munich 2023November 3, 2023 | finance.yahoo.comScinai Reports Third Quarter 2023 Financial Results and Provides Business UpdateNovember 3, 2023 | finance.yahoo.comEuropean Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot Get Scinai Immunotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNI and its competitors with MarketBeat's FREE daily newsletter. Email Address The only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. SCNI Media Mentions By Week SCNI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCNI News Sentiment▼1.440.77▲Average Medical News Sentiment SCNI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCNI Articles This Week▼21▲SCNI Articles Average Week Get Scinai Immunotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Finch Therapeutics Group News Eloxx Pharmaceuticals News Windtree Therapeutics News Entera Bio News Amgen News Gilead Sciences News Moderna News Biogen News BioNTech News argenx News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCNI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Clinton Backing Biden Replacement???The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scinai Immunotherapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.